Immunotherapies in Treatment of Bladder Cancer

The current incidence of bladder cancer diagnoses and most common symptoms that newly diagnosed patients present with.

The types of healthcare professionals who may play a role in evaluating and diagnosing bladder cancer.

Administration of systemic therapy and management of side effects in patients with bladder cancer.

Elements that are critical to ensuring that patients with bladder cancer are managed appropriately by various healthcare professionals who will likely interact with patients and their family throughout the cancer journey.

Types of educational resources available to support patients with bladder cancer as recommended by urologists and medical oncologists.

An overview of treatment guidelines available to support urologists and medical oncologists who manage patients with bladder cancer.

Frontline treatment approaches recommended by urologists and medical oncologists for patients with non-metastatic muscle-invasive bladder cancer.

First-line treatment options available for patients with high-risk non-muscle invasive bladder cancer and variables that affect treatment decisions.

The role of adjuvant therapy in nonmetastatic muscle invasive bladder cancer, and an overview of promising novel therapies in the treatment pipeline.

Types of patients with muscle invasive bladder cancer who may be candidates for a watch-and-wait approach.